Articles of the Month
Videos
Articles
Prevalence of Type 2 Inflammation in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations
M. C.Melles, J. C. C. M.Veen, D.-J.Slebos, et al.Allergy. First published: 24 March 2026
Malassezia-Induced Type 2 Immunity in Head Neck Shoulder Type Atopic Dermatitis
I.Suhrkamp, T.Heidland, C.Saft,et al.Allergy. First published: 24 March 2026
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments
R. J.Vieira, B.Sousa-Pinto, J.Bousquet, et al.Allergy. First published: 24 March 2026
Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward
E. H.Kim, J. A.Bird, H. A.Brough, et al.Allergy. First published: 23 March 2026
The Impact of Early Childhood Caries on Asthma Trajectories During the First 15 Years of Life
Handoko, C., Singh, A., Dharmage, S.C., et al.Allergy. First published: 23 March 2026
Frequency and Severity of Allergic Reactions to Non-Mandatory Labelled Allergenic Foods—Data From Two Large European Cohorts
S.Dölle-Bierke, A.Gonzalo-Fernández, D.Sabouraud-Leclerc, et al.Allergy. First published: 23 March 2026
Increased Primary Cilia Contribute to Airway Epithelium Remodeling in Asthma
G.Chen, H.Jie, C.Huang, et al.Allergy. First published: 23 March 2026
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis
Y.Zhang, J.Li, X.Li, et al.Allergy. First published: 23 March 2026
The Minimal Clinically Important Difference in Allergen Immunotherapy: The Rocky Road Toward an Evidence-Based Value
Hartenstein, D., Schmidt, S., Mahler, V. and Kaul, S.Allergy. First published:20 March 2026
Fel d 1-Expressing Plant-Derived Bioparticle: A Novel Treatment for Cat Allergy
J. A.Layhadi, L. C.Gutierrez, S. T.Keane,et al.Allergy. First published: 19 March 2026
Early Epidemiologic and Immune Predictors of Atopic Dermatitis: Reduced Cord Blood Regulatory B10 Cells in the Munich Atopy Prediction Study (MAPS)
S.Preis, S.Kaesler, M.Koeberle, et al.Allergy. First published: 19 March 2026
Involvement of B Cell Subsets in Patients With Steven Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)
F.Ahmad, J. M. P.Mateo, F. E.Joy, et al.Allergy. First published: 17 March 2026
Sphingosine 1-Phosphate Receptor 1 and 5 Reciprocally Regulate IL-13 and IL-9 Production in Atopic Dermatitis
K.Yamamura, S.Garcet, J.Gonzalez, et al.Allergy. First published: 17 March 2026
Type 2 Inflammation-Biased Arachidonic Acid Metabolite Regulates Mucosal Remodeling of Chronic Rhinosinusitis With Nasal Polyps
Y.Li, S.Liang, H.Wang, et al.Allergy. First published: 17 March 2026
Family Size and Food Allergy in Early Childhood: The Japan Environment and Children's Study
T.Nomura, H.Tanida, T.Inoue,et al.Allergy. First published: 15 March 2026
Switching Long-Term Prophylaxis to Donidalorsen for Hereditary Angioedema: 1-Year OASISplus Results
M. A.Riedl, J. A.Bernstein, J. S.Jacobs,et al.Allergy. First published: 14 March 2026
Legends of Allergology/Immunology: Marcus Maurer (†)—Physician, Scientist, Allergist and Unbeatable Communicator
L.Klimek, M.Metz, P.Staubach, and T.Zuberbier. Allergy. First published: 13 March 2026
Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia Areata
Mochón-Jiménez, C., Gay-Mimbrera, J., Dávila-Flores, V., et al.Allergy. First published: 13 March 2026
Anxiety, Depression, Schizophrenia, and Bipolar Disorder in Eosinophilic Esophagitis Patients: A Global Federated Cohort Analysis of Bidirectional Risks
H.-C.Chang, M.-C.Wu, T.Zuberbier, and S.-Y.Gau.Allergy. First published: 12 March 2026
A Case for Anti-IgE Vaccination
P.Engeroff, Z.Gharailoo, M.Vogel, and M. F.Bachmann. Allergy. First published: 11 March 2026
Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways
H.Wen, T.Kole, O. A.Carpaij, et al.Allergy. First published: 10 March 2026
Interactive Effects of Ambient Fine Particulate Matter and Ozone on Childhood Allergic Rhinitis: China, Children, Homes, Health Study
T.Chen, X.Fang, Q.Deng, et al. Allergy. First published: 09 March 2026
Associations of Chronic Rhinosinusitis and Nasal Polyps With Elevated Venous Thromboembolism Risk: Evidence From the UK Biobank Shenglong Xu, Zhaoman Wan, Xinlei Zhang, Peng Zhang, Luo Zhang, Yan Zhao
S.Xu, Z.Wan, X.Zhang, et al.Allergy. First published: 09 March 2026
Childhood Fractional Exhaled Nitric Oxide Predicts Incident Allergic Rhinitis in Adolescence and Young Adulthood
C.-H.Wang, J.-L.Huang, H.-J.Tsai, et al.Allergy. First published: 09 March 2026
Patient-Perceived Benefits of Named-Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real-World Cohort Study
D.Caimmi, A.Abouelfath, R.Lassalle, et al.Allergy. First published: 08 March 2026
Epidermal PAR2-TRPV3-IL-33 Signaling Promotes Mast Cell Recruitment and Sensory Nerve-Mast Cell Interactions in Atopic Dermatitis
J.Zhao, L.Zhou, C.Wang, et al.Allergy. First published: 08 March 2026
The OX40/OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis
K.Yamamura, D.Dahabreh, E.Del Duca, et al.Allergy. First published: 07 March 2026
Artificial Intelligence-Based Pathological Subtype Diagnosis of Nasal Polyps: A Multidimensional and Micro-Visualization Study
X.Luo, H.Li, J.Chen, et al. Allergy. First published: 07 March 2026
Correspondence to “Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis”
J.Huang and B.Wang. Allergy. First published: 07 March 2026
Chitin Is a Potent Inducer of Type 2 Airway Inflammation Independent of Endogenous Chitinolytic Activity
J.Declercq, H.Aegerter, U.Smole, et al.Allergy. First published: 06 March 2026
Algorithms in Allergy: Diagnosis and Treatment of Pollen Food Syndrome
R.Asero, L.Cecchi, V.Pravettoni, E.Scala, and D.Villalta. Allergy. First published: 06 March 2026
Making Peanuts Safer: Autoclaving as a Heat and Pressure Strategy to Increase Peanut Tolerability
Stodulski, D., Garcia-Medina, G. and Cabanillas, B. Allergy. First published: 06 March 2026
Sensitizer-Induced Basophils Accelerate Skin Re-Epithelialization via IL-4/IL-13-Mediated Macrophage Polarization
Y.Zhang, X.Peng, K.Ren, et al. Allergy. First published: 05 March 2026
Effect of Intramuscular Adrenaline on Histamine-Induced Hypotension: A Randomised Placebo-Controlled Pilot Trial
M.Weiss-Tessbach, A. M.Dizdarevic, T.Bischof, et al.Allergy. First published: 02 March 2026
Algorithms in Allergy: General Allergen Molecule-Based Algorithm for Allergen-Specific Immunotherapy
H.-J.Huang, D.Trifonova, P.Gattinger, et al.Allergy. First published: 02 March 2026
The Evolution of Sesame Seed Allergy Over Time
R.-X.Foong, G.Du Toit, H. T.Bahnson, et al. Allergy. First published: 02 March 2026
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
Dear Junior Members,
The EAACI Immunology Winter School 2026 was held in Sierra Nevada, Spain, bringing together 70 juniors selected based on their submitted scientific abstracts. The meeting was designed as an interactive and discussion-driven forum, placing young researchers at the centre of scientific exchange alongside internationally recognised faculty.
The programme combined keynote lectures with abstract presentations by juniors, ensuring direct engagement between young scientists and experts. In addition, poster sessions generated lively discussions and constructive feedback. Moreover, a dedicated Practical Course provided hands-on exposure to advanced technologies and analytical approaches, offering methodological insights readily applicable to ongoing research.
To further promote interaction among participants, and in addition to the traditional networking activities, a dedicated networking hour was organised for the first time this edition. During this session, groups of juniors had the opportunity to share experiences and ask questions to experts in a relaxed atmosphere. Topics beyond science were also discussed, including the unmet needs in biomedical sciences, opportunities for juniors, and key recommendations on how to progress in their scientific careers. Interesting debates emerged around the issues that most concern and interest junior researchers, with experts sharing their perspectives on the future of the field.
The Winter School fostered strong international networking and direct expert accessibility, enabling detailed discussions on research projects and career development. Participants benefited from focused feedback, new collaborations, and an immersive scientific atmosphere that reinforced EAACI’s commitment to supporting early-career investigators.
Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
HIGHLIGHTS FROM PAAM 2025
A group of ten Patient Organisations Committee (POC) members gathered at this wonderful venue in Palau de Congressos de Palma, Mallorca for 2025 Pediatric Allergy and Asthma Focused Meeting. Many had speaker slots giving lived experience perspectives of having children living with allergy and risk of anaphylaxis. So the EAACI PAAM Congress theme of ‘Inspiring insights for every family’ really resonated with us.
As POC, we are with EAACI to help where we can and it brings the science to a person experience, centred level. We had members a wide range of participants from Chile, USA, Turkey, UK, Sweden, Switzerland, France, Italy, Greece and Spain as POC has 36 POC members in 24 countries.
Our Chair, Ozlem Ceylan, gave an overview at the Opening Ceremony on why EAACI awareness campaigns matter, from awareness to action, so patients can feel heard and patient organisations can help lobby for policy change in their country.
POC participated in the Student Awareness Day that was set to educate 40 students aged 14-16 about allergic diseases and emergency response, with the local organising committee’s support.
One of our POC members, Esther Esteban Arroyo opened “The sister society session” with SEICAP and introduced their patient organisation, AEPNAA and their activities in Spain.
Mikaela Odemyr from Swedish Asthma and Allergy Association joined the Anaphylaxis session with a heartfelt talk, “When My Child Had Anaphylaxis: Expectations vs. Reality”. Fallon Schultz from IFPIES USA, gave a wonderful talk on parents’ perspective of dealing with a child’s FPIES journey and introduced their resources to support caregivers. On the last day of PAAM, Maria Zioga from Greece, gave a great talk, “From panic to preparedness: Building trust and resilience in food allergy care” and highlighted the importance of safety for food allergic children.
